Can aspirin ease COPD symptoms? new study seeks answers
NCT ID NCT05265299
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing different doses of aspirin to see which one best reduces inflammation in people with COPD. The goal is to find the right dose that could improve breathing and reduce flare-ups. The study involves 48 former smokers with COPD and will measure blood and urine markers of inflammation. Results will help design a larger trial to see if aspirin can improve daily symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Bayview Medical Center
RECRUITINGBaltimore, Maryland, 21224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection ease COPD and cut Flare-Ups?
- Virtual Nurse-Social worker team aims to ease symptoms for veterans with heart failure and COPD
- Double-Duty inhaler aims to ease breathing in COPD
- Could AI help pharmacists give better advice?
- New COPD drug tested across chinese, japanese, and european volunteers
- New digital tool aims to simplify care for seniors with multiple conditions